v3.25.3
TAXES ON INCOME (Tables)
12 Months Ended
Jul. 31, 2025
Income Tax Disclosure [Abstract]  
SCHEDULE OF LOSS BEFORE TAXES ON INCOME

 

   2025   2024 
   Year ended July 31, 
   2025   2024 
     
Domestic  $(23,999,920)   $23,946,952)
Foreign   (2,556,220)   (28,878,500)
Loss before taxes on income  $(26,556,140)  $(4,931,548)
SCHEDULE OF EFFECTIVE INCOME TAX

 

   2025   2024 
   Year ended July 31, 
   2025   2024 
         
Net loss before recovery of income taxes  $(26,556,140)  $(4,931,548)
Expected income tax (recovery) expense   (7,170,160)   (1,331,518)
Tax rate changes and effect of taxes of subsidiaries at foreign rates   1,448,710    1,467,021 
Share-based compensation and other non-deductible expenses   240,070    1,697,204 
Share issuance cost booked directly to equity   

(375,750

)   

-

 
Adjustments in respect of prior periods   

868,490

    

-

 
R&D Credits   (1,284,010)   (3,903,153)
Effect of spin-out transaction   -    (297,781)
Valuation allowance   6,272,650    2,368,228 
Income tax (recovery)  $-   $- 
SCHEDULE OF DEFERRED TAX ASSETS NET

 

   2025   2024 
   July 31, 
   2025   2024 
Deferred Tax Assets:          
Property and equipment  $730    731 
Marketable Securities   11,760    15,678 
Intellectual property   260,860    256,741 
Warrant liability   -    - 
Share issuance costs   310,230    376,978 
Investment in BC Therapeutics   44,650    19,172 
Operating tax losses carried forward   5,067,840    4,850,799 
Operating tax losses carried forward- USA   8,494,300    5,545,125 
Research and Development   14,240,640    10,879,373 
Total deferred tax assets   28,431,010    21,944,597 
Valuation allowance   (24,329,720)   (18,034,710)
Net deferred tax assets  $4,101,290   $3,909,887 
           
Deferred Tax Liability:          
Intellectual Property  $-   $- 
Warrant liability   (4,053,520)   (3,848,762)
Property, plant, and equipment   (47,770)   (61,125 
Total net deferred tax liabilities   (4,101,290)   (3,909,887)
Valuation allowance   -    - 
Net deferred tax assets (liabilities)  $-   $-